Intelligent Bio Solutions Statistics Share Statistics Intelligent Bio Solutions has 7.43M
shares outstanding. The number of shares has increased by 62.6%
in one year.
Shares Outstanding 7.43M Shares Change (YoY) 62.6% Shares Change (QoQ) 1.87% Owned by Institutions (%) 15.2% Shares Floating 7.33M Failed to Deliver (FTD) Shares 1,893 FTD / Avg. Volume 0.98%
Short Selling Information The latest short interest is 513.16K, so 7.43% of the outstanding
shares have been sold short.
Short Interest 513.16K Short % of Shares Out 7.43% Short % of Float 7.53% Short Ratio (days to cover) 2.15
Valuation Ratios The PE ratio is -0.57 and the forward
PE ratio is 4.34.
Intelligent Bio Solutions's PEG ratio is
0.01.
PE Ratio -0.57 Forward PE 4.34 PS Ratio 1.87 Forward PS 0.4 PB Ratio 0.7 P/FCF Ratio -0.6 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Intelligent Bio Solutions.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.57,
with a Debt / Equity ratio of 0.1.
Current Ratio 1.57 Quick Ratio 1.42 Debt / Equity 0.1 Debt / EBITDA -0.1 Debt / FCF -0.09 Interest Coverage -61.52
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $62.24K Profits Per Employee $-203.14K Employee Count 50 Asset Turnover 0.23 Inventory Turnover 2.17
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 23.08% in the
last 52 weeks. The beta is 4.59, so Intelligent Bio Solutions's
price volatility has been higher than the market average.
Beta 4.59 52-Week Price Change 23.08% 50-Day Moving Average 1.74 200-Day Moving Average 1.63 Relative Strength Index (RSI) 41.74 Average Volume (20 Days) 192,324
Income Statement In the last 12 months, Intelligent Bio Solutions had revenue of 3.11M
and earned -10.16M
in profits. Earnings per share was -6.38.
Revenue 3.11M Gross Profit 1.43M Operating Income -10.28M Net Income -10.16M EBITDA -8.81M EBIT -10.02M Earnings Per Share (EPS) -6.38
Full Income Statement Balance Sheet The company has 6.3M in cash and 871.44K in
debt, giving a net cash position of 5.43M.
Cash & Cash Equivalents 6.3M Total Debt 871.44K Net Cash 5.43M Retained Earnings -51.96M Total Assets 9.58M Working Capital 542.95K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.57M
and capital expenditures -221.43K, giving a free cash flow of -9.79M.
Operating Cash Flow -9.57M Capital Expenditures -221.43K Free Cash Flow -9.79M FCF Per Share -3.07
Full Cash Flow Statement Margins Gross margin is 45.82%, with operating and profit margins of -330.43% and -326.38%.
Gross Margin 45.82% Operating Margin -330.43% Pretax Margin -327.47% Profit Margin -326.38% EBITDA Margin -283.13% EBIT Margin -330.43% FCF Margin -314.68%
Dividends & Yields INBS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for INBS.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 29, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Jan 29, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -10.36 Piotroski F-Score 3
